EUVIMEDEUVIMED entdecken
Crossref

Design and Evaluation of Highly Selective Dopamine D4 Receptor Ligands as a Strategy for Treating Neuropsychiatric Disorders (Abstract ID: 236234)

Mohammad Alkhatib, Tian Li, Norman Nguyen, Lindsay Bourn, Salem J. Rainwater, Comfort A. Boateng, Thomas Keck

The Journal of Pharmacology and Experimental Therapeutics · 2026-05 · 393 (5) · 104109

DOI: 10.1016/j.jpet.2026.104109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2026-05. Verfasst von Mohammad Alkhatib und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Alkhatib, M., Li, T., Nguyen, N., Bourn, L., Rainwater, S. J., Boateng, C. A., & Keck, T. (2026). Design and Evaluation of Highly Selective Dopamine D4 Receptor Ligands as a Strategy for Treating Neuropsychiatric Disorders (Abstract ID: 236234). The Journal of Pharmacology and Experimental Therapeutics, 393(5), 104109. https://doi.org/10.1016/j.jpet.2026.104109

Vancouver

Alkhatib M, Li T, Nguyen N, Bourn L, Rainwater SJ, Boateng CA, et al. Design and Evaluation of Highly Selective Dopamine D4 Receptor Ligands as a Strategy for Treating Neuropsychiatric Disorders (Abstract ID: 236234). The Journal of Pharmacology and Experimental Therapeutics. 2026;393(5):104109. doi:10.1016/j.jpet.2026.104109

BibTeX
@article{Alkhatib2026,
  author = {Alkhatib, Mohammad and Li, Tian and Nguyen, Norman and Bourn, Lindsay and Rainwater, Salem J. and Boateng, Comfort A. and Keck, Thomas},
  title = {Design and Evaluation of Highly Selective Dopamine D4 Receptor Ligands as a Strategy for Treating Neuropsychiatric Disorders (Abstract ID: 236234)},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2026},
  volume = {393},
  number = {5},
  pages = {104109},
  doi = {10.1016/j.jpet.2026.104109}
}
Kostenlos starten →